CABG = coronary artery bypass graft; DAPT = dual antiplatelet therapy; DES = drug-eluting stent; ECG = electrocardiography; IVUS = intravascular ultrasound; LAD = left anterior descending; LIMA = left internal mammary artery; LV = left ventricular; MI = myocardial infarction; (N)STEMI = (non-)ST-segment elevation MI; PCI = percutaneous coronary intervention; RCT = randomised controlled trial; TIMI = thrombolysis in MI Comment: Guidelines recommend DAPT for at least 12 months after DES implantation or for 6-12 months for those not at high risk. Randomised trials have generally shown an increased bleeding risk with no significant reduction in major adverse cardiac events with prolonged therapy. The current study assessed a shorter duration of therapy in patients receiving a second-generation DES. This investigator driven, multicentre international study was stopped early due to logistic and economic constraints. The majority of patients (61.6%) had stable angina and >97% of patients received clopidogrel. Bleeding and major adverse cardiac events were similar, and the study suggested 6 months of therapy was noninferior to 12 months in this low-risk cohort using Endeavour, Nobori, Biomatrix, Promus or Xience stents.
Interventional Cardiology Research Review
The MOZART trial randomised patients undergoing PCI (n=83) to angiographic or IVUS guidance. Compared with angiography, IVUS-guided PCI was associated with a significantly lower median total volume of contrast (20.0 vs. 64.5mL [p<0.001] ) and a significantly lower median contrast-creatinine clearance ratio (1.0 vs. 0.4 [p<0.001]), with no between-group difference for in-hospital and 4-month outcomes.
Comment: Contrast-induced acute kidney injury is a potential complication of invasive coronary procedures and is associated with significant morbidity and mortality. The volume of contrast used is a major predictor of contrast-induced acute kidney injury and few studies have attempted to address this issue. This small RCT shows that aggressive use of IVUS can dramatically reduce contrast use. Lessons to be learned to reduce contrast use for routine PCI strategies include rigorous preprocedure planning, use of smaller catheters without side holes and the use of dilute contrast with smaller syringes. All patients had to be suitable for IVUS guidance, the study was not blinded and was not powered for clinical endpoints, but we should consider such strategies in patients at high risk for contrast nephropathy.
Reference: JACC Cardiovasc Interv 2014; 7(11):1287-93 Abstract Hybrid revascularization for multivessel coronary artery disease Authors: Gąsior M et al. Summary: Two hundred patients with multivessel coronary artery disease involving the LAD artery and a >70% lesion in ≥1 other major epicardial vessel who were amenable to both PCI and CABG and referred for conventional surgical revascularisation were randomised 1:1 to undergo hybrid coronary revascularisation or CABG. Among participants assigned to hybrid coronary revascularisation, 93.9% completed the procedure with the remaining 6.1% converted to standard CABG. There was no significant between-group difference at 12 months for mortality, MI, major bleeding or repeat revascularisation, and no cerebrovascular incidents were reported.
Comment:
The most advantageous part of CABG is insertion of a LIMA graft to the LAD artery, whilst the long-term efficacy of saphenous vein graft is inferior to DES patency. This prospective, single-centre, randomised, open-label pilot study suggests a hybrid strategy is feasible for patients with multivessel disease (mean syntax score 23). In the hybrid group, the aim was to perform a minimally invasive direct coronary artery bypass with LIMA to LAD artery followed by PCI to other vessels. This allowed assessment of LIMA graft patency, and antiplatelet therapy was started after surgery. Larger studies are needed to confirm this is a viable strategy for routine use.
Reference: JACC Cardiovasc Interv 2014; 7(11):1277-83 Abstract Non-ST elevation myocardial infarction with occluded artery and its clinical implications Authors: Soon K et al. Summary: The prevalences and differences between NSTEMI with occluded versus patent culprit arteries were explored in a retrospective group of 143 patients with NSTEMI who had undergone inpatient coronary angiography and with 12 months of follow-up data. Compared with patients with NSTEMI with a patent culprit artery, those with an occluded culprit artery (n=34) had significantly higher rates of hypercholesterolaemia (85 . A trend for a higher rate of HF within 12 months of discharge was apparent among patients with NSTEMI with an occluded culprit artery, but death, MI, revascularisation, arrhythmia and angina readmission rates did not differ significantly. No correlation was evident between peak creatine kinase level and the timing of percutaneous revascularisation in both groups.
Comment: Generally NSTEMI is thought to be due to incomplete occlusion of the culprit artery as opposed to STEMI where complete occlusion is usually the case. This single-centre, retrospective observational study conducted in a primary PCI centre in Victoria showed that in 24% of NSTEMIs, the culprit artery was in fact occluded. This is consistent with other studies, and clues included ECG changes showing ST depression or T-wave inversion and impaired LV dysfunction. As would be expected, these patients more often had multivessel disease and collaterals present. There was no evidence earlier PCI resulted in less myocardial damage, although the numbers were probably too small to confidently exclude this, and more research is needed to see if this is a viable strategy. Comment: Recent studies have cast doubt on the benefits of bivalirudin over heparin during primary PCI. This study is another to compare bivalirudin with unfractionated heparin, but with differing antiplatelet agents. Notably the protocol suggested terminating the bivalirudin infusion at the end of the procedure and bailout glycoprotein IIb/IIIas use was low (6.1% clopidogrel and 3.0% prasugrel groups [p=0.074]). The access site was femoral in all but one patient. Whilst the trial was stopped early due to slow recruitment, there were no apparent differences between the treatment arms for composite endpoints. Unlike other bivalirudin STEMI trials, stent thrombosis was similar in both groups (1.1% bivalirudin and 1.5% heparin arms) and bleeding rates were similar. This suggests prasugrel may reduce stent thrombosis but increase bleeding, although the study is underpowered to draw definite conclusions.
Reference: Eur Heart J 2014;35(34):2285-94 Abstract
Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease Authors: Hannan EL et al. Summary: This research compared outcomes of patients who underwent CABG and received DESs for isolated proximal LAD artery disease over a 3-year period; 5340/6064 patients received DESs, and they were propensity matched into 715 CABG and/or DES pairs to minimise selection bias. No significant difference was seen for mortality alone or mortality, MI and/or stroke, but CABG was associated with significantly fewer repeat revascularisations (7.09% vs. 12.98% [p=0.0007]). A Cox proportional analysis confirmed no significant differences in the 3-year mortality rate (adjusted hazard ratio 1.14 [95% CI 0.70-1.85]) and the 3-year mortality, MI and/or stroke rate (1.15 [0.76-1.73]), and also confirmed the lower repeat revascularisation rate (0.54 [0.36-0.81 
]).
Comment: There are at least nine RCTs comparing CABG with PCI in patients with single-vessel LAD artery disease; however, the total number of patients (n=1207) is modest and all but one was before the DES era. This study used New York State's clinical registries to provide up-to-date comparisons between these two modalities. There appear to be no differences in mortality, MI and stroke between the two groups, but a higher rate of subsequent revascularisation in the stented group. Depending on the perceived difficulty of PCI (chronic total occlusion, complex bifurcation) and quality of the distal vessel for LIMA anastomosis and patient comorbidities, a heart team approach may be ideal in deciding which treatment is best for an individual patient.
POST-MI PATIENTS REMAIN AT HIGH AND PERSISTENT RISK
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After a successful intervention, what more can we do to protect them from their underlying disease? Comment: In order to offer a 24/7 primary PCI service, cardiologists need to be on call and may need to perform procedures in the 'middle of the night' (defined here as between midnight and 7am). In other settings, such extended work hours are associated with poor psychomotor performance. This paper used the CathPCI registry to examine outcomes of sleep-deprived versus nonsleep-deprived operators, and suggests that whilst it occurs infrequently (2.4%), there appears to be no adverse signal. Whilst representing the largest published analysis of interventional cardiologist fatigue and patient safety, there are a number of limitations including exactly how much rest each operator got, whether more complex cases were rescheduled and how often more rested nurses or fellows may have helped avert potential errors of judgment.
Reference: JACC Cardiovasc Interv 2015; 8(1_PA) , precluding the use of cardiac magnetic resonance oedema imaging for estimating the at-risk area. When cardiac magnetic resonance-independent coronary angiography jeopardy scores were used to estimate the at-risk area, remote ischaemic conditioning was associated with a significant improvement in the myocardial salvage index (0.42 vs. 0.28 [p=0.03] ).
Comment: Despite the increasing prevalence of primary PCI, significant morbidity and mortality of STEMI remains, which may relate to reperfusion injury. Remote ischaemic conditioning has emerged as a potential low cost and safe intervention, which may have therapeutic benefit. This randomised single-centre study examined a surrogate MI endpoint and suggested benefit of remote ischaemic conditioning. Patients were randomised on arrival to hospital to remote ischaemic conditioning or control. The remote ischaemic conditioning protocol consisted of a standard blood pressure cuff placed on the upper arm and inflated to 200mm Hg and left inflated for 5 minutes. It was then deflated for 5 minutes and the cycle repeated a total of four times prior to primary PCI. The results are intriguing and a large multicentre RCT powered for hard cardiac endpoints is now needed.
Reference: JACC Cardiovasc Interv 2015; 8(1_PB):178-88 Abstract
